Press Releases

Press Releases

The latest press releases from A4LI can be found below.

Press Releases

  • A4LI Announces D.C. Fly-In Event to Propel Longevity Biotech Initiatives
    A4LI Announces D.C. Fly-In Event to Propel Longevity Biotech Initiatives November 28, 2023 – The Alliance for Longevity Initiatives (A4LI) is excited to announce its inaugural D.C. Fly-In event, set for January 24-25, 2024. PDF DC Fly-In 2024 Press ReleaseDC Fly-In 2024 Press Release 
    READ MORE
  • Guide to Applying for ARPA-H’s Open Broad Agency Announcement
    Guide to Applying for ARPA-H’s Open Broad Agency Announcement July 14, 2023 – Here is how you can apply to the Advanced Research Projects Agency for Health’s (ARPA-H) first Agency-wide Open Broad Agency Announcement (Open BAA) PDF PDFGuide to Applying for ARPA-H’s Open Broad Agency Announcement 
    READ MORE
  • Governor of Montana Approves Bill Expanding Patient Access to Experimental Treatments
    Governor of Montana Approves Bill Expanding Patient Access to Experimental Treatments May 12, 2023 – The Alliance for Longevity Initiatives (A4LI) celebrates the recent signing of Montana Senate Bill No. 422 by Governor Greg Gianforte. PDF The Advanced Approval Pathway for Longevity MedicinesThe Advanced Approval Pathway for Longevity Medicines 
    READ MORE
  • Announcing the Formation of the ‘Longevity Science Caucus’
    Announcing the Formation of the ‘Longevity Science Caucus’ February 21, 2023 – The Alliance for Longevity Initiatives (A4LI) applauds the efforts of Congressman Gus Bilirakis (R-FL) and Congressman Paul Tonko (D-NY) for co-chairing the newly formed bipartisan Congressional Caucus for Longevity Science. Official A4LI Press Release for Longevity Caucus Announcing the Formation of the ‘Longevity Science Caucus’ 
    READ MORE
  • Announcing Changes to our Membership/Sponsorship System
    Announcing Changes to our Membership/Sponsorship System November 1, 2022 – Over the past year, A4LI has seen an enormous outpouring of support and growth. Whether you are a member, a sponsor or a subscriber to our newsletter, we are truly grateful to have you with us on this journey. That is why we believe it is time ...
    READ MORE
  • Polling (Still) Indicates Widespread Bipartisan Support for Aging Research
    Polling (Still) Indicates Widespread Bipartisan Support for Aging Research August 9, 2022 – A new national poll of registered voters in the United States demonstrates broad bipartisan support for advancing research into longevity treatments that would extend healthy human lifespan. The poll, which was conducted by Public Policy Polling on behalf of The Alliance for Longevity ...
    READ MORE
  • Support for Healthy Lifespan Extension Remains Stable, But More Education on the Field is Needed
    Support for Healthy Lifespan Extension Remains Stable, But More Education on the Field is Needed May 3, 2022 – A new national poll of registered voters in the United States demonstrates broad support for scientific interventions that would increase healthy human lifespan. The poll, which was conducted by Public Policy Polling on behalf of The Alliance ...
    READ MORE
  • The Alliance for Longevity Initiatives Announces Formation and Members of Scientific Advisory Board
    The Alliance for Longevity Initiatives Announces Formation and Members of Scientific Advisory Board March 2, 2022 – The Alliance for Longevity Initiatives (A4LI), a nonprofit organization advocating for social and political action around the issues of combating age-related chronic conditions and increasing healthy human lifespan, today announced the formation of a Scientific Advisory Board comprised of ...
    READ MORE
  • The Alliance for Longevity Initiatives Announces Appointment of Paul Cherukuri, Ph.D. to Board of Directors
    The Alliance for Longevity Initiatives Announces Appointment of Paul Cherukuri, Ph.D. to Board of Directors February 11, 2022 – The Alliance for Longevity Initiatives (A4LI) today announced the appointment of. Paul Cherukuri to the A4LI Board of Directors. Dr. Cherukuri joined as the tenth member of the Board in November 2021. Read the full press release.
    READ MORE
  • New Poll Demonstrates Bipartisan Support for Therapies that Target Aging and Associated Research
    New Poll Demonstrates Bipartisan Support for Therapies that Target Aging and Associated Research January 20, 2022 – A new national poll of registered voters in the United States shows that the majority of respondents would utilize pharmaceutical intervention to target aspects of aging if the drugs or therapies were safe, effective, affordable, and available to all. ...
    READ MORE